Long-term outcomes of pneumococcal meningitis in childhood and adolescence
- 19 January 2011
- journal article
- research article
- Published by Springer Science and Business Media LLC in European Journal of Pediatrics
- Vol. 170 (8), 997-1006
- https://doi.org/10.1007/s00431-010-1390-5
Abstract
A vaccine to prevent pneumococcal meningitis (PM) has recently been introduced. However, contemporary data to inform cost-effectiveness analysis and justify its routine use are sparse. We examined the cognitive, educational, psychological and social outcomes of PM in childhood. We completed a population-based case–control study in two regions of the UK. Children and young people currently between 3 and 20 years of age that had been diagnosed with PM ≤14 years of age were identified from active regional surveillance. Controls were siblings or neighbours of similar age. Standardised questionnaires and neuropsychological testing was administered to assess IQ, educational attainments, memory, psychological distress, quality of life and hearing impairment. Data were available on 97 patients and 93 controls. Eighty-four patients had a sibling/neighbour-matched control. Both matched and unmatched analyses were completed, and results of the 84 matched comparisons were highly similar to the unmatched. For the total sample, controls were similar in age, ethnicity and socioeconomic status. Median age at meningitis was 11 months. Median time between meningitis and assessment was 6.0 years. In the matched analysis, partial or profound hearing impairment was reported in 14% of patients and 1% of controls. Patients had significantly lower mean full-scale IQ (p = 0.05), verbal IQ (p = 0.0008), numeracy (p = 0.02), total quality of life (p = 0.04), school functioning (p = 0.005), psychosocial functioning (p = 0.001) and psychological difficulties (p = 0.01). Parents of patients reported greater functional disability (p = 0.008), impairment in all aspects of quality of life (p = 0.001) and psychological difficulties (p < 0.0006). Findings for IQ were not materially different when analyses were repeated only in those without hearing impairment. In multivariate regression analysis that included both case–control status and hearing status, both being a patient (p = 0.001) and having profound hearing impairment (p = 0.001) were independently associated with lower full-scale IQ. Conclusions Pneumococcal meningitis is associated with major sequelae. Our findings strongly support the introduction of pneumococcal conjugate vaccine as part of routine childhood vaccination programmes internationally.Keywords
This publication has 31 references indexed in Scilit:
- Health related quality of life in survivors of pneumococcal meningitisActa Paediatrica, 2009
- Early Vancomycin Therapy and Adverse Outcomes in Children With Pneumococcal MeningitisPEDIATRICS, 2006
- Long-term beneficial effects of dexamethasone on intellectual and neuropsychological outcome of children with pneumococcal meningitisScandinavian Journal of Infectious Diseases, 2006
- Clinical data and factors associated with poor outcome in pneumococcal meningitisEuropean Journal of Pediatrics, 2005
- Show me the child at seven II: childhood intelligence and later outcomes in adolescence and young adulthoodJournal of Child Psychology and Psychiatry, 2005
- Outcome of invasive pneumococcal disease: a UK based studyArchives of Disease in Childhood, 2000
- Pneumococcal meningitis in the North East Thames Region UK: epidemiology and molecular analysis of isolatesEpidemiology and Infection, 1996
- Pneumococcal Meningitis in Children: Prognostic Indicators and OutcomeClinical Infectious Diseases, 1995
- Rising IQ Scores in British Children: Recent EvidenceJournal of Child Psychology and Psychiatry, 1992
- The Functional Disability Inventory: Measuring a Neglected Dimension of Child Health StatusJournal of Pediatric Psychology, 1991